Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data

Health Economics

Volumn 14, Issue 3, 2005, Pages 217-230

  Bagust, Adrian ^a,b   Beale, Sophie ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL MANAGEMENT SCHOOL   (United Kingdom)

Author keywords

Diabetic complications; EQ 5D; Euroqol; Type 2 diabetes; Utility

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BLINDNESS; DIABETIC ANGIOPATHY; DIABETIC FOOT; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE SEVERITY; EUROPE; FEMALE; HEALTH STATUS; HUMAN; INSULIN TREATMENT; ISCHEMIC HEART DISEASE; LIMB AMPUTATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SELF EVALUATION; STATISTICAL MODEL; STROKE; VISUAL ANALOG SCALE;

COST OF ILLNESS; DIABETES MELLITUS, TYPE 2; EUROPE; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; QUESTIONNAIRES;

EID: 14944339043     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/hec.910     Document Type: Article

References (15)

1. Bagust A, Hopkinson PK, Maier W, Currie CJ. An economic model of the long-term health care burden of type II diabetes. Diabetologia 2001; 44: 2140-2155.
2. Jacobson MA, De Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care 1994; 17(4): 267-274.
3. Gulliford MC, Mahabir D. Relationship of health-related quality of life to symptom severity in diabetes mellitus: a study in Trinidad and Tobago. J Clin Epidemiol 1999; 52(8): 773-780.
4. UK Prospective Diabetes Study Group. Quality of life in type 2 diabetes patients is affected by complications but not by intensive policies to improve blood glucose control (UKPDS 37). Diabetes Care 1999; 22(7): 1125-1136.
5. Glasgow RE, Ruggiero L, Eakin EG et al. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care 1997; 20(4): 562-567.
6. Lloyd A, Sawyer W, Hopkinson P. Impact of long term complications on quality of life in patients with type 2 diabetes not using insulin. Value Health 2001; 4: 392-400.
7. Hanninen J, Takala J, Keinanen-Kiukaanniemi S. Quality of life in NIDDM patients assessed with the SF20 questionnaire. Diabetes Res Clin Pract 1998; 42(1): 17-27.
8. Redekop WK, Koopmanschap MA, Stolk RP et al. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care 2002; 25(3): 458-463.
9. Clarke P, Gray A, Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making 2002; 22(4): 340-349.
10. Dolan P, Gudex C, Kind P, Williams A. A social tariff for EuroQol: results from a UK general population survey. Discussion paper no. 138. Centre for Health Economics, University of York, 1995.
11. Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycaemic control in patients with type 2 diabetes mellitus. J Am Med Assoc 1998; 280(17): 1490-1496.
12. Rose M, Burkert U, Scholler G et al. Determinants of the quality of life of patients with diabetes under intensified insulin therapy. Diabetes Care 1998; 21(11): 1876-1885.
13. Massi-Benedetti M. The cost of diabetes type II in Europe. The CODE-2 study. Diabetologia 2002; 45(Suppl): S1-S4.
14. Koopmanschap M. Coping with type II diabetes: the patient's perspective. Diabetologia 2002; 45(Suppl): S18-S22.
15. Badia X, Roset M, Herdman M, Kind P. A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making 2001; 21(1): 7-16.